=Edwards Lifesciences (EW) reported earnings on Wed 25 Oct 2017 (b/o)

Edwards Lifesciences misses by $0.02, misses on revs; guides Q4 EPS in-line, revs in-line

• Reports Q3 (Sep) earnings of $0.84 per share, excluding non-recurring items, $0.02 worse than the Capital IQ Consensus of $0.86; revenues rose 11.1% year/year to $821.5 mln vs the $833.85 mln Capital IQ Consensus.
• Co issues in-line guidancefor Q4, sees EPS of $0.84-0.94, excluding non-recurring items, vs. $0.91 Capital IQ Consensus Estimate; sees Q4 revs of $855-895 mln vs. $869.55 mln Capital IQ Consensus Estimate.